215 related articles for article (PubMed ID: 24419011)
21. Neoadjuvant sunitinib effectiveness in T4 renal clear cell carcinoma: a case report.
Ricciardulli S; Del Biondo D; Cicero C; Leo G; Zeccolini G; Celia A
Urologia; 2015; 82(2):109-13. PubMed ID: 25050998
[TBL] [Abstract][Full Text] [Related]
22. Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma.
Vaz MA; Pachón V; Grande E; Ferreiro R; Carrato A
Anticancer Drugs; 2011 Sep; 22(8):817-21. PubMed ID: 21566523
[TBL] [Abstract][Full Text] [Related]
23. Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.
Fokt RM; Templeton A; Gillessen S; Ohlschlegel C; Schmid HP
Urol Int; 2009; 83(1):122-4. PubMed ID: 19641373
[TBL] [Abstract][Full Text] [Related]
24. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].
Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A
Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524
[TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma: complete response.
Calvo OF; Vázquez DD; López MR; Aparicio LM
Anticancer Drugs; 2010 Jan; 21 Suppl 1():S17-8. PubMed ID: 20110782
[TBL] [Abstract][Full Text] [Related]
26. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
Park CY
Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
[TBL] [Abstract][Full Text] [Related]
27. Metastatic collecting duct carcinoma of the kidney treated with sunitinib.
Tazi EM; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
World J Surg Oncol; 2011 Jul; 9():73. PubMed ID: 21752265
[TBL] [Abstract][Full Text] [Related]
28. Metastatic renal clear cell carcinoma to the rectum, lungs, ilium, and lymph nodes: A case report.
Zheng G; Li H; Li J; Zhang X; Zhang Y; Wu X
Medicine (Baltimore); 2017 Jan; 96(1):e5720. PubMed ID: 28072710
[TBL] [Abstract][Full Text] [Related]
29. Brain metastasis in renal cell cancer responding to sunitinib.
Koutras AK; Krikelis D; Alexandrou N; Starakis I; Kalofonos HP
Anticancer Res; 2007; 27(6C):4255-7. PubMed ID: 18214028
[TBL] [Abstract][Full Text] [Related]
30. The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.
Desar IM; Mulder SF; Stillebroer AB; van Spronsen DJ; van der Graaf WT; Mulders PF; van Herpen CM
Acta Oncol; 2009; 48(6):927-31. PubMed ID: 19452305
[No Abstract] [Full Text] [Related]
31. [Case of multiple lung metastases of renal cell carcinoma failing to respond to Interferon-alpha (IFN-alpha) and sunitinib but markedly responding to everolimus].
Nishikimi T; Tsuzuki T; Yamauchi Y; Yoshida S; Ishida R; Yamada H; Yokoi K; Kobayashi H
Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):530-5. PubMed ID: 23819366
[TBL] [Abstract][Full Text] [Related]
32. [A case of interstitial lung disease due to sunitinib].
Sekiguchi Z; Takizawa A; Takeshima T; Tsuchiya F; Iwasaki A; Matsuyama S; Hirooka N
Hinyokika Kiyo; 2012 Sep; 58(9):481-5. PubMed ID: 23070386
[TBL] [Abstract][Full Text] [Related]
33. Persistent complete response after single-agent sunitinib treatment in a case of TFE translocation positive relapsed metastatic pediatric renal cell carcinoma.
Chowdhury T; Prichard-Jones K; Sebire NJ; Bier N; Cherian A; Sullivan MO; O'Meara A; Anderson J
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e1-3. PubMed ID: 22995920
[TBL] [Abstract][Full Text] [Related]
34. Brain metastases in patients with renal cell cancer receiving new targeted treatment.
Helgason HH; Mallo HA; Droogendijk H; Haanen JG; van der Veldt AA; van den Eertwegh AJ; Boven E
J Clin Oncol; 2008 Jan; 26(1):152-4. PubMed ID: 18165649
[No Abstract] [Full Text] [Related]
35. Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
Michaelson MD; Iliopoulos O; McDermott DF; McGovern FJ; Harisinghani MG; Oliva E
N Engl J Med; 2008 May; 358(22):2389-96. PubMed ID: 18509125
[No Abstract] [Full Text] [Related]
36. A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety.
Uemura H; Shinohara N; Yuasa T; Tomita Y; Fujimoto H; Niwakawa M; Mugiya S; Miki T; Nonomura N; Takahashi M; Hasegawa Y; Agata N; Houk B; Naito S; Akaza H
Jpn J Clin Oncol; 2010 Mar; 40(3):194-202. PubMed ID: 19897852
[TBL] [Abstract][Full Text] [Related]
37. [Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case].
Tsuchiyama K; Ito H; Ishida H; Itoh H; Yokoyama O
Hinyokika Kiyo; 2011 Nov; 57(11):615-8. PubMed ID: 22166824
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary metastasis of renal cell carcinoma resected sixteen years after nephrectomy.
Yoshida J; Nagai K; Hasebe T; Takahashi K; Nishimura M; Otsuka S; Nishiwaki Y; Kodama T
Jpn J Clin Oncol; 1995 Feb; 25(1):20-4. PubMed ID: 7877260
[TBL] [Abstract][Full Text] [Related]
39. When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report.
Sbitti Y; Debbagh A; Slimani K; Mahi M; Errihani H; Ichou M
J Med Case Rep; 2018 Mar; 12(1):80. PubMed ID: 29554941
[TBL] [Abstract][Full Text] [Related]
40. Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma.
Heng DY; Rini BI; Garcia J; Wood L; Bukowski RM
Clin Genitourin Cancer; 2007 Dec; 5(7):446-51. PubMed ID: 18272027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
